BioPlus Acquisition Corp. (NASDAQ:BIOSU – Get Rating) fell 0.1% on Wednesday . The stock traded as low as $10.19 and last traded at $10.19. 112 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 16,203 shares. The stock had previously closed at $10.20.
BioPlus Acquisition Trading Down 0.1 %
The firm has a fifty day simple moving average of $10.16 and a 200 day simple moving average of $10.07.
Get BioPlus Acquisition alerts:Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. Cubist Systematic Strategies LLC purchased a new position in BioPlus Acquisition during the 3rd quarter worth $343,000. Robinson Capital Management LLC increased its holdings in BioPlus Acquisition by 55.2% during the 1st quarter. Robinson Capital Management LLC now owns 25,293 shares of the company's stock worth $252,000 after purchasing an additional 9,000 shares during the period. State Street Corp purchased a new position in BioPlus Acquisition during the 1st quarter worth $184,000. Condor Capital Management increased its holdings in BioPlus Acquisition by 238.5% during the 2nd quarter. Condor Capital Management now owns 7,515 shares of the company's stock worth $74,000 after purchasing an additional 5,295 shares during the period. Finally, Wolverine Asset Management LLC increased its holdings in BioPlus Acquisition by 21,946.7% during the 2nd quarter. Wolverine Asset Management LLC now owns 3,307 shares of the company's stock worth $33,000 after purchasing an additional 3,292 shares during the period.
BioPlus Acquisition Company Profile
(Get Rating)BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Featured Stories
- Get a free copy of the StockNews.com research report on BioPlus Acquisition (BIOSU)
- Lucid Motors Faces a Reality That May Cloud a Bullish Perception
- Institutions Put Bottom In Rite Aid Shares
- Here's Why You Should Steer Clear of the FedEx Bounce
- Why Did Viking Therapeutics Stock Skyrocket
- NIKE, Inc Swooshes Higher On Results And Outlook
Receive News & Ratings for BioPlus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPlus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.